CVC Capital Partners enters into exclusive discussions with 3i and NiXEN with a view to acquiring their shareholding in Vedici

23 Jun 2014

Vedici, 3i, NiXEN and CVC Capital Partners have entered into exclusive negotiations for the sale of 3i and NiXEN’s shareholding in Vedici to CVC. 

The transaction would represent a key milestone in the growth strategy of Vedici, led since the formation of the group in 2000 by its founders Jérôme Nouzarède and Michel Bodkier. The founders and managers of the group will increase their shareholding alongside CVC. 

The transaction takes place in the broader context of the ongoing consolidation of the sector and remains conditional upon customary approvals. 

3i, NiXEN and Vedici advisors: Lazard, BNP Paribas, Société Générale. 
CVC Capital Partners advisors: JP Morgan, Rothschild. 
Founders and managers advisor: Callisto. 

-Ends-

For further information, contact:

3i Group plc
Kathryn van der Kroft    
Tel: +44 20 7975 3021
Email: kathryn.vanderkroft@3i.com

Notes to editors:

About 3i Group
3i is a leading international investment manager focused on mid-market Private Equity, Infrastructure and Debt Management across Europe, North America and Asia. For further information, please visit: www.3i.com   

About Vedici 
Formed in 2000 by its Chairman, Jérôme Nouzarède, and Dr. Michel Bodkier, Vedici is today one of France’s leading players in private healthcare with 35 clinics primarily focused on medicine, surgery and obstetrics, with a workforce of 5,300 employees. 
www.vedici.fr